Salivary Gland Infection Market Research Report- Global Forecast till 2027

salivary gland infection market information, by diagnosis (plain radiography, sialography, and others), by treatment (medication, surgery, aspiration, and others), by end user- Forecast till 2027

ID: MRFR/Pharma/2506-HCR | February 2021 | Region: Global | 76 pages

Market synopsis of salivary gland infection market:


Market Scenario:


Salivary gland infection is one of the most common medical condition across the globe. These infections are mostly caused due to bacteria or viruses. Salivary gland infection affects salivary duct or gland.


Increasing prevalence of various salivary gland infections, changing disease patterns, and environmental changes are major drivers for the market growth. Rising funding for R&D and clinical trials are leading to improved product development is another key factor for market growth. Improved hygiene practices, growing awareness about self-care and advanced diagnosis and treatment options are important driving forces for the market.


The salivary gland infection market is growing at the CAGR of ~6.7% during the forecast period and expected to reach US$ 3622.6 million by 2023.


Study objectives of salivary gland infection market:



  • To provide detailed analysis of the salivary gland infection market structure with historical and forecast revenue for the next 6 years of the various segments and sub-segments.

  • To provide insights about the key drivers, restraints, opportunities and challenges affecting the growth of salivary gland infection market

  • To provide analysis of the market with respect to four main geographies and their countries – the Americas, Europe, Asia-Pacific, and Middle East & Africa.

  • To provide detailed analysis of the market segmented by diagnosis, treatment, end user, and its sub-segments.

  • To provide a detailed analysis of salivary gland infection market mainly based on Value Chain analysis, Porter’s Five Forces, Price analysis, and Supply Chain analysis etc.

  • To provide a detailed country level analysis of the market with respect to the current market size and future prospects.

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the salivary gland infection market

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the salivary gland infection market


FIGURE 1                   SALIVARY GLAND INFECTION MARKET SHARE BY END USER, 2016 (%) SALIVARY GLAND INFECTION MARKET SHARE BY END USER, 2016


Sources: National Center for Biotechnology Information, U.S. Food and Drug Administration, U.S. National Library of Medicine, Directorate of Industries, Annual report, White paper, Company Presentation


Intended Audience:



  • Salivary gland infection drugs manufacturers

  • Salivary Gland Infection drugs and treatment providers

  • Hospitals and clinics

  • Medical Research laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors


Research Methodology: Research Methodology salivary gland infection market


Sources: National Center for Biotechnology Information, U.S. Food and Drug Administration, U.S. National Library of Medicine, Directorate of Industries, Annual report, White paper, Company Presentation


Segments:      


salivary gland infection market has been segmented on the basis of diagnosis which comprises of Plain radiography, sialography, high-resolution ultrasonography, Computed tomography (CT), Magnetic Resonance Imaging (MRI), radionuclide scintigraphy, and others. Sialography is further sub-segmented into CT sialography (ultrafast technique), fluoroscopic/conventional sialography (with or without digital subtraction), and MR sialography.


On the basis of treatment, the market has been segmented into medication, surgery, aspiration, home care, and others. Medication is further sub-segmented into antibiotics and others. Antibiotics are further sub-segmented into dicloxacillin, cephalosporins, clindamycin, and others. Surgery includes removal of part of the parotid salivary gland, removal of all of the parotid salivary gland, removal of the submandibular salivary gland, and others. Home remedies include increased water intake, rest, refraining from smoking, massaging the gland with heat, and others.


On the basis of end user, it is segmented into hospitals & clinics, medical research centers, academic institutes, and others.


Regional analysis of salivary gland infection market:                


Considering the global scenario of the market, Americas holds the largest market share due to various factors such as increasing number of patients with various salivary gland infections and related disorders. European salivary gland infection market is the second largest where the west European countries are dominating the largest market share. Prevalence of various salivary gland infection is rising in Asia Pacific region. Additionally, increasing healthcare spending and rapidly changing healthcare sector, and government initiatives to improve public health are major growth drivers for Asia Pacific salivary gland infection market. Due to low knowledge of disease and treatments, low-income, and limited access to healthcare facilities, Middle East and Africa (ME&A) is likely to have a limited growth in the market.


Key Players for salivary gland infection market:                             


Some of the key players in this market are: AbbVie Inc. (US), Allergan (Republic of Ireland), AstraZeneca (UK), FUJIFILM Holdings Corporation (Japan), General Electric Company (US), GlaxoSmithKline plc. (UK), Johnson & Johnson Services, Inc. (US), Merck & Co., Inc. (US), Pfizer Inc.(US), Siemens Healthcare GmbH (Germany), and others The report for Global Salivary Gland Infection Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions



Speak to Analyst Ask for Customization

Table of Content

1. Report Prologue

2. Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

2.3 Market Structure

2.4. Market Segmentation

3. Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Mega Trends

4.5 Macroeconomic Indicators

5. Market Factor analysis

5.1 Value Chain Analysis

5.2 Porters Five Forces

5.3 Demand & Supply: Gap Analysis

5.4 Pricing Analysis

5.5 Investment Opportunity Analysis

5.6 Merger and Acquisition Landscape

5.7 Upcoming trends

5.7.1 Market trends

5.7.2 Technological trends

5.7.3 Insurance & Regulations

5.7.4 Others

6. Global salivary gland infection market by diagnosis

6.1 Plain radiography

6.2 Sialography

6.2.1 CT sialography (ultrafast technique)

6.2.2 Fluoroscopic/conventional sialography (with or without digital subtraction)

6.2.3 MR sialography

6.3 Computed tomography (CT)

6.4 Magnetic resonance imaging (MRI)

6.5 Radionuclide scintigraphy

6.6 High-resolution ultrasonography

6.7 Others

7. Global Salivary gland infection market by treatment

7.1 Medications

7.1.1 Antibiotics

7.1.1.1 Dicloxacillin

7.1.1.2 Cephalosporins

7.1.1.3 Clindamycin

7.1.14 Others

7.1.2 Others

7.2 Surgery

7.2.1 Removal of part of the parotid salivary gland

7.2.2. Removal of all of the parotid salivary gland

7.2.3 Removal of the submandibular salivary gland

7.2.4 Others

7.3 Aspiration

7.4 Home care

7.4.1 Water intake

7.4.2 Rest

7.4.3 Massaging the gland with heat

7.4.4 Stop smoking

7.4.5 Others

7.5 Others


8. Global Salivary Gland Infection market by end user

8.1 Hospitals & clinics

8.2 Medical research centers

8.3 Academic Institutes

8.4 Others

9. Global Salivary Gland Infection Market by region

9.1 Introduction

9.2 America

9.2.1 North America

9.2.1.1 The US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia

9.4.1 China

9.4.2 India

9.4.3 Japan

9.4.4 South Korea

9.4.5 Rest of Asia

9.5 Pacific

9.6 Middle East and Africa

9.6.1 UAE

9.6.2 Saudi Arabia

9.6.3 Egypt

9.6.4 Rest of Middle East and Africa

10. Competitive landscape

11. Company profile

12. Conclusion

12.1 Key findings

12.1.1 From CEO’s viewpoint

12.1.2 Unmet needs of the market

12.2 Key companies to watch

12.3 Prediction of salivary gland infection market

13. Appendix